MQ Investors Have Opportunity To Lead Marqeta, Inc. Securities Fraud Lawsuit With The Schall Law Firm

LOS ANGELES, Dec. 23, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Marqeta, Inc. (“Marqeta” or “the Company”) MQ for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between August 7, 2024 and November 4, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before February 7, 2025.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Marqeta failed to inform investors of regulatory challenges threatening its business outlook. The Company was forced to cut its guidance for the fourth quarter of 2024. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Marqeta, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

See also <!DOCTYPE html><html lang="en"><head> <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <title>Uncovering Undervalued Gems: A Dive into Bargain Stock Picks</title></head><body> <article> <h2>Embracing Value in Market Flux</h2> <p>Bargain stocks are currently in the spotlight, stealing the limelight from once high-flying growth stocks that now teeter on the edge of a market bubble. In this era of market shifts, the allure of value stocks beckons, offering long-term growth potential and enticing price points. These undervalued gems, hidden beneath the glitz of market stars, present a golden opportunity for investors seeking diversification and solidity in their portfolios.</p> <h3>The Hunt for Genuine Value</h3> <p>However, the pursuit of the best-value stocks demands cautious navigation. Uncovering true value amidst the sea of discounted options requires meticulous analysis. Value traps—stocks that appear cheap but carry hidden risks—lurk behind the facade of discounted prices. Thorough due diligence is paramount to discerning between fleeting bargains and sustainable investment prospects. A prudent investor's focus lies in identifying companies that not only offer immediate value but also harbor a viable, long-term growth trajectory to propel investment gains.</p> <h2>Discovering the Underdogs: Pfizer (PFE)</h2> <img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/pfe-stock-3-300x169.jpg" alt="Pfizer logo on Pfizer building. Pfizer is an American pharmaceutical corporation."> <p>Source: Manuel Esteban / Shutterstock.com</p> <ul> <li>% Below 52-week high: 36.3%</li> </ul> <p><strong>Pfizer</strong> (NYSE:<strong>PFE</strong>) has weathered a tumultuous year, seeing its stock price plummet by over 30% due to a decline in revenues from its COVID-19 vaccine. Yet, beneath the grim exterior lies a resilient contender. A closer examination reveals an overreaction in the market, magnifying pessimism towards PFE stock. Coupled with an enticing 6% dividend yield, Pfizer emerges as a compelling value play.</p> </article></body></html>Financial Luminaries Shine Bright: H&R Block and JD

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/mq-investors-have-opportunity-to-lead-marqeta-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302338129.html

SOURCE The Schall Law Firm

Market News and Data brought to you by Benzinga APIs

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

Market News

MQ Investors Have Opportunity to Lead Marqeta, Inc. Securities Fraud Lawsuit with the Schall Law Firm – Marqeta (NASDAQ:MQ)